You can view 1 more answer this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Knight Therapeutics Inc. (GUD $6.45)
- $6.45 Cap: $642M
- View GUD Profile
- View Questions on GUD
- View Reports on GUD

Q: Hello,
Any plans to update your research report on GUD now that they have bought back Paladin Labs?
Thankyou.

Asked by Chris on May 28, 2025

5i Research Answer:

We discontinued coverage of GUD in September 13. We will likely look at again after a few quarters of Palladin results but cannot guarantee it will be added back yet to the research list.

Let us help YOU reach your financial goals today!

Start your FREE trial today and enjoy all the benefits of a 5i Membership including:

Access to a team of experts ready to answer your investments question
Instant access to over 100,000 archived questions
A community of like-minded investors
Peace of mind knowing that 5i Research has only YOUR best interests in mind

First Name *

Last Name *

E-mail *

Password *

I have read and agree to the Terms of Use